Roche deployed over 3,500 Nvidia Blackwell GPUs to establish a powerful AI factory. This move creates the largest announced GPU footprint in the pharmaceutical industry. The infrastructure spans hybrid-cloud and on-premises facilities across the United States and Europe.
Roche plans to embed AI across its entire value chain from initial research to commercialization. This initiative expands a strategic collaboration with Nvidia that began in 2023. The expanded compute power allows scientists to build sophisticated predictive models for drug discovery.
The technology aims to shorten the path from biological insight to patient treatments. Roche expects the infrastructure to accelerate the development of both new medicines and diagnostic tools.